Amneal Pharmaceuticals, Inc.
(NYSE : AMRX)

( )
AMRX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.47%38.270.9%$1237.63m
JNJJohnson & Johnson -0.61%147.500.7%$891.02m
MRKMerck & Co., Inc. -0.72%81.050.6%$638.10m
ABBVAbbVie, Inc. -0.76%92.541.9%$595.17m
BMYBristol-Myers Squibb Co. 2.70%61.301.0%$584.67m
AZNAstraZeneca Plc 0.45%56.201.2%$579.27m
LLYEli Lilly & Co. -0.95%152.871.1%$442.45m
NVSNovartis AG 0.00%83.420.2%$138.06m
GSKGlaxoSmithKline Plc -0.56%40.980.2%$134.66m
OPKOPKO Health, Inc. 3.76%5.6611.2%$134.16m
MISTMilestone Pharmaceuticals, Inc. -1.79%8.800.0%$119.59m
RGENRepligen Corp. -0.78%154.677.1%$69.38m
NVONovo Nordisk A/S -2.26%63.620.1%$64.90m
PRNBPrincipia Biopharma, Inc. -3.14%87.240.0%$58.72m
IMRNImmuron Ltd. 1.74%11.140.0%$53.75m

Company Profile

Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.